Patents

  1. Screening assays to identify therapeutic agents for amyloidosis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys & T.L. Blundell). US Patent No. 6,126,918, granted 3 October 2000.
  2. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,045,499, granted 16 May 2006.
  3. Therapeutic agent for depletion of an unwanted protein population from plasma. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 418 905, granted 2 May 2007.
  4. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys & P.N. Hawkins). UK Patent No. 2420498, granted 30 October 2007.
  5. Therapeutic and diagnostic agents for amyloidosis. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 0 714 405, granted 26 March 2008.
  6. CRP binding agents. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,390,795, granted 24 June 2008.
  7. Use. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). International Patent Application No. WO 2009/000926, published 31 December 2008.
  8. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 503 800, granted 28 October 2009.
  9. Treatment and prevention of tissue damage. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,615,543, granted 10 November 2009.
  10. Compound and use thereof in the treatment of amyloidosis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys, S.V. Ley, A.J. Morrison, V. Bellotti, S.P. Wood, S.E. Kolstoe and M.D. Smith). International Patent Application No. WO 2009/040405 A1, published 2 April 2009.
  11. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). US Patent No. 7,659,299, granted 9 February 2010.
  12. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). Australian Patent No. 2004244815, granted 25 March 2010.
  13. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 7,691,897, granted April 2010.
  14. Therapeutic agent for depletion of an unwanted protein population from plasma. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). European Patent No. 1 820 501, granted 14 September 2011.
  15. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). European Patent No. 1 633 345, granted 21 September 2011.
  16. Therapeutic agent. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). US Patent No. 8,173,694, granted 8 May 2012.
  17. Combinations of SAP depleting agents and anti‑SAP antibodies. Pentraxin Therapeutics Limited (Inventor: M.B. Pepys). Singapore Patent No. 201206A, granted 31 August 2012.
  18. Compounds inhibiting the binding of SAP for treating osteoarthritis. Pentraxin Therapeutics Limited (Inventors: M.B. Pepys and P.N. Hawkins). Canadian Patent No. 2,528,706, granted 30 October 2012.

Page last modified on 22 nov 13 17:36 by E A ( Beth ) Jones